Search PubMed⌕ Search

Biomedical subjects

J Nunez

Publications and source records attributed to J Nunez.

At least 55 records · Page 3Linked to original sources
PubMed1991

High molecular weight tau: preferential localization in the peripheral nervous system.

Using epitope mapping we have demonstrated that a high molecular weight protein (Mr approximately 115 x 10(3)) present in brain and spinal cord is a member of the tau family of microtubule-associated proteins. Antibodies directed against the amino-terminal, middle and carboxyl-terminal portions of tau recognize this protein. A limited survey of neuronal tissues has shown that this high molecular weight tau protein is present in brain, spinal cord, dorsal root ganglia, dorsal and ventral roots and peripheral nerves. High molecular weight tau protein is expressed at higher levels in spinal cord than in brain and is the only form of tau detected in the adult peripheral nervous system.

Animals↗
PubMed1990

Protein TAU variants present in paired helical filaments (PHFs) of Alzheimer brains.

Polyclonal anti-TAU antisera directed against native Tau protein and the NH2-terminal side of the mouse TAU sequence were used to determine the nature of the TAU variants present in Alzheimer brains and in PHFs. These antibodies labelled specifically neurofibrillary tangles and plaque neurites in Alzheimer brains. On immunoblots of PHF extracts, two entities of 69 and 130 kDa were identified. These TAU-related species were absent from control brains. Protein immunoblot of total Alzheimer and control supernatants were shown to contain the same 4-5 TAU variants but none of the 69 and 130 TAU-related entities found in PHFs. These data suggest that specific TAU species are present in PHFs.

Alzheimer Disease↗
PubMed1990

GFAP turnover during astroglial proliferation and differentiation.

The expression and turnover of the glial fibrillary acidic protein (GFAP) were studied in astroglial primary cultures during postnatal proliferation and maturation. 1. Immunocytochemical studies demonstrated that in immature proliferating astrocytes. GFAP was expressed as a filamentous organized crown around the nucleus whereas in the maturating cells, a GFAP labelled network began to radiate throughout the cytoplasm and GFAP was highly expressed in the astroglial processes. 2. GFAP turnover was studied at 3 periods of culture. The decay of radioactivity from prelabelled GFAP was followed from day 4-12 (immature stage), 11-19 (maturing stage) and 21-29 (morphologically differentiated stage). GFAP displayed a biphasic decay kinetic at each considered period. Two pools of GFAP distinctly appeared. The first one was a fast decaying pool with a half life of 16-18 h and of 5-6 days for the stable one. The unstable pool decreased from 70% to 30% of the total incorporated radioactivity from the proliferating stage to the most mature stage, whereas the stable pool increased proportionally.

Animals↗
PubMed1990

Expression of Tau protein and Tau mRNA in the cerebellum during axonal outgrowth.

UNLABELLED: "In situ" hybridization and immunohistochemical analysis of the expression of Tau mRNAs and Tau proteins in the developing cerebellum showed that: 1. At early postnatal stages Tau mRNAs are expressed in the deeper region of the external granular layer (EGL II) i.e. in the cells that begin to migrate from the proliferative zone. Little labeling was seen in the upper layer (EGL I) where the cerebellar interneurons actively proliferate during the first two postnatal weeks. Anti-Tau antibodies failed to detect Tau proteins both in EGL I and II. 2. Tau transcripts were also clearly detected in the migrating cells present in the molecular layer; no Tau immunoreactivity was seen in this layer. This suggests that Tau mRNAs remain very poorly translated in the migrating granule cells and in the other interneurons. 3. Tau proteins begin to be detected at postnatal day 8 in the molecular layer but only at the level of the parallel fibers that are present in the Purkinje cell dendritic field. This suggests that the Tau mRNAs transcribed in the migrating cells are not actively translated for several days and that Tau proteins accumulate only in the more mature sections of their axons, the parallel fibers. IN CONCLUSION: Tau mRNAs are transcribed in the migrating cells several days before Tau proteins are actively translated and transported to their axons. Tau proteins accumulation occurs only at the end of granule cell migration i.e. when the parallel fibers interact with their post-synaptic counterparts, the dendrites of the Purkinje cells. Thus, axonal outgrowth and differentiation seem to be a multistep process.

Aging↗
PubMed1990

Interaction of the two structural domains of calmodulin with mature and immature rat brain microtubules.

The inhibitory effect of calmodulin on the assembly of mature and immature rat brain microtubules was compared with that of the two major structural domains of this protein, the COOH-terminal fragment (amino acids 78-148) and the NH2-terminal fragment (amino acids 1-77), to determine the calmodulin structural domain responsible for the inhibitory effect on microtubule assembly. Microtubules prepared during the early stages of brain development, i.e., during intensive neurite outgrowth, are more sensitive to inhibition by the Ca2(+)-calmodulin complex than those obtained from adult brain. Significant inhibition of immature microtubule assembly was observed with both fragments in the absence of Ca2+, but the effects were more important when Ca2+ was present. With adult brain microtubules, the two fragments remained without effect on assembly in the absence of Ca2+, whereas some inhibition was seen in its presence but only with the COOH-terminal polypeptide. Under all these conditions, the COOH-terminal fragment was always more active than the NH2-terminal fragment on microtubule polymerization, albeit to a lesser extent than native calmodulin.

Aging↗
PubMed1989

Timing of expression of tau and its encoding mRNAs in the developing cerebral neocortex and cerebellum of the mouse.

The expression of tau mRNA and of the corresponding encoded protein variants was studied during postnatal development in two brain regions differing in their timing of differentiation: the cerebral neocortex and the cerebellum. (a) The expression of tau mRNA was different in the two regions. Maximal contents were found at early stages in the cerebral neocortex, with a 10-fold decrease at later stages. In the cerebellum, two peaks of tau mRNA were observed soon after birth and in adulthood, with minimal values at postnatal day 6. (b) The expression of total tau proteins was similar to that of their encoding mRNAs in the cerebral neocortex, i.e., high concentrations after birth and low contents at later stages. In contrast, two peaks of tau proteins were observed in the cerebellum: the first perinatally and the second with a maximum at postnatal day 15. (c) Both in the cerebral neocortex and especially in the cerebellum, increasing concentrations of mature tau variants were expressed at late developmental stages, i.e., when total tau protein contents were decreased. In conclusion, the fluctuations in expression of tau and of its encoding mRNA seen in the cerebellum seem to reflect differences in the timing of differentiation of the various cell types, i.e., the macroneurons and the interneurons, present in this brain region. The adult tau variants appear in both the neocortex and the cerebellum only at late developmental stages, i.e., when most of the circuitry has been established, although these two regions markedly differ in their timing of differentiation.

Animals↗
PubMed1989

Developmental expression of the glial fibrillary acidic protein mRNA in the central nervous system and in cultured astrocytes.

The expression of glial fibrillary acidic protein (GFAP)-mRNA during mouse brain development and in astroglial primary cultures has been investigated by using two approaches: Northern-blot evaluation using a specific cDNA probe, and cell-free translation associated with immunoprecipitation. During brain maturation (4-56 days postnatal), the GFAP-mRNA underwent a biphasic evolution. An increase was observed between birth and day 15 (i.e., during the period of astroglial proliferation), which was followed by a decrease until day 56 (i.e., during astroglial cell differentiation). At older stages (300 days), an increase was observed, which might reflect gliosis. During astroglial in vitro development (7-32 days in culture), the GFAP-mRNA showed similar variations. An increase, observed during the period of astroglial proliferation (7-18 days), was followed by a decrease which occurred in parallel to marked changes in cell shape, cell process outgrowth, and the organization and accumulation of gliofilaments. During the same culture period (7-32 days), alpha-tubulin mRNA, which was used as an internal standard, did not vary significantly. These results show that the increase of the GFAP protein and of gliofilaments observed both in vivo and in vitro during astroglial differentiation cannot be ascribed to an accumulation of the GFAP-mRNA. It might be that more than one mechanism regulates the levels of free and polymerized GFAP and of its encoding mRNA.

Animals↗
PubMed1988

Dendritic and axonal distribution of the microtubule-associated proteins MAP2 and tau in the cerebellum of the nervous mutant mouse.

The fate of the different types of axons and dendrites in the nervous mutant mouse has been studied with antibodies raised against the two major microtubule-associated proteins, MAP2 and tau. These proteins are specific markers of dendrites and axons, respectively. (1) Immunoblot analysis of cerebellar extracts showed that MAP2 concentration is markedly reduced (by approximately 90%) in the adult mutant. A 60% decrease was already noticed at day 20 postnatal, i.e., when all the Purkinje cells are present in their normal location and in apparent normal number. (2) Immunohistochemical studies performed at an adult stage with anti MAP2 antibodies showed marked alterations in the shape of the dendrites of the rare surviving Purkinje cells present in the lateral sections of the cerebellum of the mutant. In the vermis, where 50% of the cells survive in adulthood, the MAP2 antibody revealed both clusters of cells with a normal density and an intricated and extensive pattern of dendritic arborization and isolated cells showing either an apparently normal or an altered dendritic tree. (3) At day 20 postnatal the same antibody revealed, in the lateral sections severe abnormalities of the dendrites of the Purkinje cells which were different from those seen in adulthood in the vermis. Thus, although few or any Purkinje cells are dead at this stage, a large proportion of them have already profound dendritic alterations. In contrast, in the vermis the Purkinje cells and their dendritic tree are undistinguishable at this stage from those of the unaffected normal mice. (4) Immunoblot and immunohistochemical studies performed with the anti Tau antibody suggested that the majority of the axonal fibers of the cerebellum were present both at day 20 postnatal and at later adult stages. This suggests that, although deprived of their postsynaptic targets these axons can survive for a long time after Purkinje cell death. However, an anti-neurofilament monoclonal antibody which stains specifically the axons of the basket cells, revealed an altered morphology of the basket cell nest in the regions devoid of Purkinje cells. (5) In conclusion the alterations in the morphology of dendrites seem to represent an early event of Purkinje cell degeneration and to be correlated with a marked decrease in expression of MAP2. It remains unclear, however, whether such changes in expression of MAP2 represent a primary effect of the mutation or if it is only a precocious result of Purkinje cell degeneration.

Animals↗
PubMed1988

Both adult and juvenile tau microtubule-associated proteins are axon specific in the developing and adult rat cerebellum.

Several antibodies directed against the heterogeneous microtubule-associated protein group tau have been used to determine the immunocytochemical localization of these proteins in the developing rat cerebellum. Immunoblot analysis of brain extracts showed that both monoclonal and polyclonal anti-tau antibodies revealed not only the adult tau proteins (50,000-70,000 mol. wt) but also the immature (48,000 mol. wt) tau form. Immunocytochemical studies showed that, whatever the stage of development, anti-tau antibodies stained several types of axonal fibres. The Purkinje cell bodies and their dendrites were never significantly labelled. This means that immature tau is, as adult tau, localized essentially in axons. Axonal labelling seems to follow the cerebellar developmental pattern. For instance, the climbing fibres which reach the cerebellum during the embryonic life were stained soon after birth by the anti-tau antibodies. In contrast, the parallel fibres, that begin to develop perinatally, do not express tau at early (5 days) postnatal stages; a clear labelling of the deeper parallel fibres (which are more mature than the superficial ones) was seen at day 10 after birth in the vicinity of the developing dendrites of the Purkinje cells. This suggests that (1) the appearance of tau immunoreactivity reflects a certain stage of maturity of the parallel fibre; (2) both immature and mature tau microtubule-associated proteins seem to be axon specific in the developing rat cerebellum.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗
PubMed1988

Expression of the mRNA for tau proteins during brain development and in cultured neurons and astroglial cells.

Two tau cDNA probes of 1.6 and 0.3 kilobases (kb) have been used to study the expression of the tau mRNAs during mouse brain development and in highly homogeneous primary cultures of neurons and astrocytes. (1) Whatever the stage, a 6-kb mRNA was detected with the two probes. In the astrocytes a 6-kb mRNA hybridized clearly only with the 1.6-kb probe. (2) During brain development the abundance of tau mRNA increases from a late fetal stage (-4 days) until birth, remains high until 6 days postnatal, and then markedly decreases to reach very low values in adulthood. Such a marked decrease in the abundance of tau mRNA parallels that of alpha-tubulin mRNA. These data suggest that: (1) depending on the stage of development and on the cell type (neurons or astrocytes) tau mRNAs of the same size encode several tau proteins differing in molecular weight: several tau proteins are expressed either during early stages of development (juvenile tau proteins of 48 kilodaltons) or in adulthood (mature tau proteins of 50-70 kilodaltons) or are specific of the astrocyte (83 kilodaltons). (2) The expression of the two major components of axonal microtubules, tubulin and tau proteins, seems to be developmentally coordinated.

Animals↗
PubMed1986

Expression of microtubule-associated proteins during the early stages of neurite extension by brain neurons cultured in a defined medium.

Immunoblotting analysis was used to identify the microtubule-associated proteins (MAPs) present in cultures of mouse brain neurons. Polyclonal antibodies were raised against the two main adult brain MAPs, i.e., MAP2 (300 kDa) and tau (60-70 kDa). Whatever the stage of the culture, which was performed in a defined medium (3 or 6 days), the anti-MAP2 serum detected several high-molecular-weight components (including MAP2) and an entity with 62-65 kDa. Anti-tau revealed essentially a major peak of 48 kDa (young tau) but also slightly cross-reacted with the 62-65 kDa entity. During the culture period (0-6 days) the cells developed progressively a dense neuritic network; the concentration of the different MAPs increased in parallel but at different rates depending on the different species. The increase in concentration of the high-molecular-weight components occurred before that of 48-kDa tau. This suggests that high-molecular-weight MAPs and 48-kDa tau might be involved respectively in the initiation and elongation of neurites. In contrast, and since the main developmental changes in tau composition seen in vivo did not occur during the time course of the culture, this transition might be related to later events of neuronal differentiation.

Animals↗
PubMed1986

Protein synthesis in astrocytes: 'spontaneous' and cyclic AMP-induced differentiation.

Primary cultures of mouse astrocytes have been used to study astroglial protein synthesis during 'in vitro' differentiation. Spontaneous age-related differentiation was compared to the effect of DBcAMP or forskolin, a drug which directly stimulates the adenylate cyclase and induces 'morphological differentiation' in these cells. Cell differentiation was followed in parallel by phase contrast microscopy and immunofluorescence techniques. Two antisera, one raised against GFA, the other against microtubule-associated protein 2 (MAP2) were used. Anti-GFA serum labelled the cells as early as 7 days in vitro. Anti-MAP2 serum revealed a dense fibrous network at later stages of the culture, whereas the dividing astroblasts appeared poorly stained by this antibody. Both phase contrast microscopy and immunofluorescence techniques suggested that most of the cells spontaneously differentiate after 3 weeks of culture even in the absence of DBcAMP or forskolin. Forskolin, while accelerating differentiation after 7 days of culture, produced smaller cells than DBcAMP and had biphasic effects on cell morphology. Mono- and two-dimensional gel electrophoresis of the 35S-methionine labelled cells also showed that the major changes in protein synthetic activity occur spontaneously during the time course of the culture. Whatever the stage of the culture, DBcAMP or forskolin induced changes in the synthesis of only a few proteins. However, depending on the culture stage the proteins, which were positively or negatively controlled by these drugs, were not the same.

Animals↗
PubMed1985

Immunological characterization of microtubule-associated proteins specific for the immature brain.

Immunoblotting analysis was used to detect the microtubule-associated proteins present at different stages of rat brain development. Polyclonal antibodies were raised against the two main adult brain microtubule-associated proteins: MAP-2 (300 kDa) and TAU (60-70 kDa). Whatever the stage of development, anti-MAP-2 serum detected high molecular mass proteins and at immature stages a protein of 62 kDa. This protein which has previously been referred to as 'young TAU slow' is, therefore, immunologically related to MAP-2. The anti-TAU serum (but not the anti-MAP-2 serum) detected at immature stages of development a 48 kDa protein which also disappears at adulthood. This 48 kDa entity which has been referred to as 'young TAU fast' is progressively replaced by the closely spaced bands (60-70 kDa) of adult TAU proteins. The 62 and 48 kDa proteins appear therefore to be immunologically distinct and represent two microtubule-associated proteins specific to the immature brain.

Animals↗